An organisation, formed in 2003, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), is an example of international collaboration. The first meeting of this group took place in August 2003 in New York City followed by meetings, including discussions held in a psoriatic workshop at the seventh meeting of Outcome Measures in Rheumatology (OMERACT) in May 2004. GRAPPA counts in 2005 over 125 physicians and other individuals who have a dedicated interest in clinical care, education, and research involving patients with psoriasis and psoriatic arthritis (PsA). The mission of GRAPPA includes the following elements:
increasing awareness and early diagnosis of psoriasis and PsA
development and validation of research assessment tools to measure clinical status and disease outcome
evaluation of treatment modalities
supporting and conducting basic research on disease pathophysiology
fostering communication between rheumatologists, dermatologists, representatives of patient advocacy organisations, biopharmaceutical companies, regulatory agencies, and others who are interested in the advancement of care of psoriasis and PsA.
GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA)
« Back to Glossary Index